Future of Geriatric Dermatologic Therapy

Özet

With rapid changes in medical and economic scales, the aging of the existing population and the decline in birth rates have led to profound shifts in many service sectors. Perhaps the most significant of these is the provision of medical care and treatment services tailored to the needs of the aging population. The evolution of treatment methods, the increasingly personalized and scrutinized use of medications, and the emergence of genetic therapies have brought notable changes to the health outcomes of geriatric patients. Assuming that this trend continues, we can anticipate a future where treatments are easier to use, have fewer interactions, and yet are more potent than those we currently prescribe. The ability of each stakeholder in the healthcare system to rapidly adapt to these medical, economic, and psychosocial changes will fundamentally alter many of the treatments we use today and open the door to an entirely new reality.

Referanslar

United Nations. World Population Ageing. URL www.un.org/en/development/ desa/population/publications/pdf/ageing/WPA2015_Report.pdf

United Nations. World population ageing report 2017. URL www.un.org/ en/development/desa/population/publications/pdf/ageing/WPA2017_ Report.pdf (last accessed 1 May 2018).

United Nations (2015). World Population Prospects: The 2015 Revision

Sjerobabski Masnec I, Poduje S. Photoaging. Coll Antropol. 2008 Oct;32 Suppl 2:177-80. PMID: 19140280.

Farage MA, Miller KW, Elsner P, Maibach HI. Characteristics of the aging skin. Adv Wound Care (New Rochelle) 2013

Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol 2007

Katoh N, Tennstedt D, Abellan van Kan G, Saint Aroman M, Loir A, Bacqueville D, Duprat L, Guiraud B, Bessou-Touya S, Duplan H. Gerontodermatology: the fragility of the epidermis in older adults. J Eur Acad Dermatol Venereol. 2018 Nov;32 Suppl 4:1-20. doi: 10.1111/jdv.15253. PMID: 30365203.

Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int 2016; 16: 75–86

Armanious M, Vender R. A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis. J Cutan Med Surg. 2021 Jan-Feb;25(1):38-44. doi: 10.1177/1203475420952423. Epub 2020 Sep 1. PMID: 32870031.

Hoy SM. Baricitinib: A Review in Moderate to Severe Atopic Dermatitis. Am J Clin Dermatol. 2022 May;23(3):409-420. doi: 10.1007/s40257-022-00684-1. Epub 2022 May 3. Erratum in: Am J Clin Dermatol. 2022 Sep;23(5):747. doi: 10.1007/s40257-022-00717-9. PMID: 35503162; PMCID: PMC9061224.

Silverberg JI, Gooderham MJ, Paller AS, Deleuran M, Bunick CG, Gold LFS, Hijnen D, Calimlim BM, Lee WJ, Teixeira HD, Hu X, Zhang S, Yang Y, Grada A, Platt AM, Thaçi D. Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). Am J Clin Dermatol. 2024 May;25(3):485-496. doi: 10.1007/s40257-024-00853-4. Epub 2024 Mar 25. PMID: 38528257; PMCID: PMC11070400.

Iznardo H, Roé E, Serra-Baldrich E, Puig L. Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis. Pharmaceutics. 2023 Jan 23;15(2):385. doi: 10.3390/pharmaceutics15020385. PMID: 36839707; PMCID: PMC9960033.

Van Molle P, Mylle S, Verbelen T, De Boom C, Vankeirsbilck B, Verhaeghe E, Dhoedt B, Brochez L. Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis: Complementary information that may affect decision-making. Exp Dermatol. 2023 Oct;32(10):1744-1751. doi: 10.1111/exd.14892. Epub 2023 Aug 3. PMID: 37534916.

Rosselló-Jiménez D, Docampo S, Collado Y, Cuadra-Llopart L, Riba F, Llonch-Masriera M. Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey. Eur Geriatr Med. 2024 Apr 14. doi: 10.1007/s41999-024-00970-7. Epub ahead of print. PMID: 38615289.

Nasr-Esfahani E, Samavi S, Karimi N, Soroushmehr SMR, Jafari MH, Ward K, et al. Melanoma detection by analysis of clinical images using convolutional neural network. Conf Proc IEEE Eng Med Biol Soc. 2016;2016:1373–6.

Huang K, Wu X, Li Y, Lv C, Yan Y, Wu Z, Zhang M, Huang W, Jiang Z, Hu K, Li M, Su J, Zhu W, Li F, Chen M, Chen J, Li Y, Zeng M, Zhu J, Cao D, Huang X, Huang L, Hu X, Chen Z, Kang J, Yuan L, Huang C, Guo R, Navarini A, Kuang Y, Chen X, Zhao S. Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application. J Med Internet Res. 2023 Mar 16;25:e44932. doi: 10.2196/44932. PMID: 36927843; PMCID: PMC10131673.

Gustafson E, Pacheco J, Wehbe F, Silverberg J, Thompson W. A Machine learning algorithm for identifying atopic dermatitis in adults from electronic health records 2017 IEEE International Conference on Healthcare Informatics (ICHI) 2017:83–90

Han SS, Park GH, Lim W, Kim MS, Na JI, Park I, et al. Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomycosis datasets by region-based convolutional deep neural network. PLoS One. 2018;13:e0191493.

Dhillon S. Beremagene Geperpavec: First Approval. Drugs. 2023 Aug;83(12):1131-1135. doi: 10.1007/s40265-023-01921-5. PMID: 37432558

Sayfalar

487-492

Gelecek

17 Şubat 2026

Lisans

Lisans